tradingkey.logo
tradingkey.logo
Search

Metagenomi Inc

MGX
Add to Watchlist
1.190USD
-0.030-2.46%
Close 07-31 16:00ETQuotes delayed by 15 min
44.80MMarket Cap
LossP/E TTM

MGX Income Statement

You can find the annual or quarterly income statement of Metagenomi Inc here for insights into the performance and operational efficiency of Metagenomi Inc.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
Total revenue
-69.76%1.25M
-59.32%3.91M
-24.80%8.66M
-57.45%8.51M
-63.02%4.13M
-22.46%9.61M
-6.87%11.51M
76.48%20.01M
28.90%11.16M
121.61%12.40M
151.64%12.36M
--11.34M
--8.66M
--5.59M
--4.91M
Revenue
-69.76%1.25M
-59.32%3.91M
-24.80%8.66M
-57.45%8.51M
-63.02%4.13M
-22.46%9.61M
-6.87%11.51M
76.48%20.01M
28.90%11.16M
121.61%12.40M
151.64%12.36M
--11.34M
--8.66M
--5.59M
--4.91M
Operating expenses
-19.13%25.84M
-6.48%28.28M
-7.08%31.50M
-19.99%29.50M
-20.51%31.95M
-7.23%30.24M
-2.48%33.90M
25.84%36.87M
51.12%40.19M
52.59%32.59M
120.13%34.76M
--29.30M
--26.59M
--21.36M
--15.79M
R&D expenses
-23.24%19.30M
-7.18%21.50M
-3.71%25.28M
-20.53%22.51M
-20.03%25.14M
-6.43%23.16M
-2.16%26.26M
24.86%28.32M
56.18%31.44M
64.41%24.75M
139.04%26.84M
--22.68M
--20.13M
--15.06M
--11.23M
Depreciation, depletion, and amortization
-6.11%1.27M
-11.02%1.30M
-2.93%1.32M
1.99%1.33M
6.68%1.36M
21.65%1.46M
18.20%1.36M
29.48%1.31M
51.37%1.27M
67.04%1.20M
130.80%1.15M
--1.01M
--841.00K
--719.00K
--500.00K
Operating profit
11.62%-24.59M
-18.15%-24.37M
-2.04%-22.84M
-24.46%-20.99M
4.17%-27.82M
-2.11%-20.62M
0.05%-22.38M
6.12%-16.86M
-61.85%-29.03M
-28.10%-20.20M
-105.89%-22.39M
---17.96M
---17.94M
---15.77M
---10.88M
Net non-operating interest income (expenses)
Non-operating interest income
-46.69%1.54M
-41.05%1.88M
-38.77%2.21M
-37.50%2.48M
-26.61%2.89M
-12.00%3.20M
-6.47%3.62M
0.23%3.98M
-1.72%3.93M
88.19%3.63M
258.63%3.87M
--3.97M
--4.00M
--1.93M
--1.08M
Non-operating interest expense
----
----
----
----
----
----
----
----
----
--0.00
--0.00
----
----
--0.00
--0.00
Special income (expenses)
----
100.00%0.00
100.00%0.00
---1.29M
----
---7.13M
---2.06M
----
----
--0.00
--0.00
--2.87M
----
--0.00
--0.00
Other non-operating income (expenses)
87.50%-1.00K
77.55%-11.00K
96.49%-2.00K
-37.25%-70.00K
84.00%-8.00K
-1125.00%-49.00K
32.94%-57.00K
-418.75%-51.00K
-4900.00%-50.00K
-107.27%-4.00K
-273.47%-85.00K
--16.00K
---1.00K
--55.00K
--49.00K
Income before tax
7.59%-23.05M
8.58%-22.49M
1.21%-20.63M
-53.53%-19.86M
0.82%-24.94M
-48.52%-24.61M
-12.17%-20.88M
-16.45%-12.94M
-80.45%-25.15M
-20.22%-16.57M
-90.91%-18.61M
---11.11M
---13.94M
---13.78M
---9.75M
Income tax
-89.80%10.00K
102.81%34.00K
88.89%-234.00K
102.00%44.00K
--98.00K
-144.31%-1.21M
-274.63%-2.11M
-215.86%-2.20M
-100.00%0.00
222.22%2.73M
91.13%1.21M
--1.90M
--2.20M
--846.00K
--631.00K
Income after tax
7.91%-23.06M
3.72%-22.53M
-8.63%-20.39M
-85.38%-19.91M
0.43%-25.04M
-21.27%-23.40M
5.28%-18.77M
17.44%-10.74M
-55.88%-25.15M
-31.91%-19.29M
-90.93%-19.82M
---13.01M
---16.13M
---14.63M
---10.38M
Net income from continuous operations
7.91%-23.06M
3.72%-22.53M
-8.63%-20.39M
-85.38%-19.91M
0.43%-25.04M
-21.27%-23.40M
5.28%-18.77M
17.44%-10.74M
-55.88%-25.15M
-31.91%-19.29M
-90.93%-19.82M
---13.01M
---16.13M
---14.63M
---10.38M
Net income attributable to controlling interests
7.91%-23.06M
3.72%-22.53M
-8.63%-20.39M
-85.38%-19.91M
0.43%-25.04M
-21.27%-23.40M
5.28%-18.77M
17.44%-10.74M
-55.88%-25.15M
-31.91%-19.29M
-90.93%-19.82M
---13.01M
---16.13M
---14.63M
---10.38M
Net income attributable to common shareholders
7.91%-23.06M
3.72%-22.53M
-8.63%-20.39M
-85.38%-19.91M
0.43%-25.04M
-21.27%-23.40M
5.28%-18.77M
17.44%-10.74M
-55.88%-25.15M
-31.91%-19.29M
-90.93%-19.82M
---13.01M
---16.13M
---14.63M
---10.38M
Basic earnings per share
9.28%-0.61
4.15%-0.60
-6.93%-0.55
-82.73%-0.54
43.15%-0.68
-21.99%-0.63
3.32%-0.51
15.41%-0.29
-176.74%-1.19
-31.91%-0.51
-90.93%-0.53
---0.35
---0.43
---0.39
---0.28
Diluted earnings per share
9.28%-0.61
4.15%-0.60
-6.93%-0.55
-82.73%-0.54
43.15%-0.68
-21.99%-0.63
3.32%-0.51
15.41%-0.29
-176.74%-1.19
-31.91%-0.51
-90.93%-0.53
---0.35
---0.43
---0.39
---0.28
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

How do I read Metagenomi Inc's income statement on TradingKey?

Start with total revenue, then review cost of revenue, gross profit, operating expenses, operating profit, income before tax, net income, and EPS. Revenue shows the scale of the business, while margins and profit lines show whether that revenue is being converted into earnings efficiently.

What is the difference between quarterly and annual income statements?

A quarterly income statement shows performance for a three-month fiscal period, while an annual income statement summarizes the full fiscal year. Quarterly data is useful for tracking recent momentum and seasonality, while annual data is better for judging long-term growth, profitability, and business cycles.

What does YOY mean on the income statement page?

YOY means year over year. It compares a financial metric with the same period in the previous year, such as this quarter's revenue versus revenue in the same quarter last year. YOY comparison helps investors see growth trends while reducing the impact of normal seasonal changes.

Which income statement metrics matter most when analyzing MGX stock?

Important metrics include revenue growth, gross profit, gross margin, operating profit, operating margin, net income, EPS, R&D expenses, SG&A expenses, and tax expense. Investors usually look at these together to judge whether the company is growing, controlling costs, and improving profitability.

What was Metagenomi Inc's revenue at year end?

Metagenomi Inc reported 25.21M in revenue for fiscal year 2025, up from 52.29M in the previous year.

How much revenue did Metagenomi Inc report in the most recent quarter?

Metagenomi Inc reported 1.25M in revenue for the most recent quarter, an increase of -69.76% year over year.

What was Metagenomi Inc's net income for the year?

Metagenomi Inc posted -87.87M in net income for fiscal year 2025.

How much net income did Metagenomi Inc post in the last quarter?

Metagenomi Inc reported -23.06M in net income for the latest quarter。

What was Metagenomi Inc's annual operating profit?

Metagenomi Inc's operating income was -96.01M for fiscal year 2025.

How is EPS related to the income statement?

EPS, or earnings per share, is based on net income divided by the number of shares outstanding. It helps investors understand how much profit the company generated for each share, but it should be reviewed alongside share count changes, margins, cash flow, and valuation metrics.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.